According to the recent study the human microbiome market is projected to reach an estimated $3 billion by 2030 at a CAGR of 17.8% from 2024 to 2030. Growth in this market is primarily driven by increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing.
Browse 119 figures/charts
and 99 tables in this 209-page report to understand trends, opportunities and
forecast in human microbiome market by product (prebiotics, probiotics, food,
medical food, and drugs), disease type (infectious, metabolic/endocrine,
cancer, blood, and neurological), research technology (proteomics,
metabolomics, and genomics), application (therapeutics and diagnostics), and
region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that
probiotics will remain the largest segment over the forecast period due to
increasing health concerns; growing awareness of the relationship between
nutrition, diet, and health; and increasing penetration of the probiotic market
in dairy and other foods.
Infectious disease will
remain the largest disease type over the forecast period due to increasing
cognizance of the negative effects of antibiotic use on the natural flora (such
as disruptions), which has highlighted the need for specific bacterial-targeted
therapies for infectious diseases.
Download sample by clicking on human microbiome market.
North America will
remain the largest region over the forecast period due to increasing incidence
of lifestyle-related diseases, rising awareness of preventive healthcare,
availability of funding for microbiome research, and growing acceptance of
probiotic products. APAC is expected to witness the highest growth over the
forecast period due rising chronic diseases caused by changes in lifestyle and
growing interest in human microbiome treatment approaches.
Enterome, Seres
Therapeutics, 4D Pharma, DuPont, Vedanta Biosciences, Osel, Merck & Co.,
Second Genome, and Metabiomics Corporation are the major supplier in the human
microbiome market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Transcritical Co2 Systems Market in Canada
Wind Power Coatings Market in Canada
Wollastonite Powder Market in Canada
Bagging Machine Market in Canada
No comments:
Post a Comment